Written by Mark O'Neill
ACE inhibitors and ARBs are the cornerstone of diabetic nephropathy treatment, reducing protein leakage and slowing kidney damage. Maximal dosing, not early discontinuation, is key to protection - and combining them with other drugs can be dangerous.